Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt flag Egypt · Delayed Price · Currency is EGP
2.050
+0.020 (0.99%)
At close: Mar 27, 2025

EGX:MCRO Income Statement

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
519.97526.01729.61594.26430.5
Revenue Growth (YoY)
-1.15%-27.91%22.78%38.04%-
Cost of Revenue
196.85230.36167.97120.3992.36
Gross Profit
323.12295.65561.64473.87338.14
Selling, General & Admin
274.82353.03314.18256.02155.56
Other Operating Expenses
0.5926.579.9613.73-2.02
Operating Expenses
311.09478.04327.29270.25156.6
Operating Income
12.03-182.39234.35203.62181.55
Interest Expense
-46.6-29.48-13.48-8.15-3.16
Interest & Investment Income
5.771.982.81.061.82
Currency Exchange Gain (Loss)
-9.3914.233.68-0.060.04
Other Non Operating Income (Expenses)
-4.65-49.95---2.57
EBT Excluding Unusual Items
-42.85-245.62227.35196.46177.67
Impairment of Goodwill
--21.42---
Gain (Loss) on Sale of Investments
3.29----
Asset Writedown
--3---
Pretax Income
-39.56-270.03227.35196.46177.67
Income Tax Expense
-1.512.653.4848.4942.54
Earnings From Continuing Operations
-38.04-272.64173.88147.97135.13
Minority Interest in Earnings
-0.05-0.01-0.04-0.04-0
Net Income
-38.1-272.65173.84147.93135.13
Net Income to Common
-38.1-272.65173.84147.93135.13
Net Income Growth
--17.51%9.47%-
Shares Outstanding (Basic)
570564572577577
Shares Outstanding (Diluted)
570564572577577
Shares Change (YoY)
1.12%-1.46%-0.88%--
EPS (Basic)
-0.07-0.480.300.260.23
EPS (Diluted)
-0.07-0.480.300.260.23
EPS Growth
--17.09%11.40%-
Free Cash Flow
-86.76-44.44129.6344.4438.88
Free Cash Flow Per Share
-0.15-0.080.230.080.07
Dividend Per Share
--0.1070.069-
Dividend Growth
--54.70%--
Gross Margin
62.14%56.21%76.98%79.74%78.55%
Operating Margin
2.31%-34.67%32.12%34.26%42.17%
Profit Margin
-7.33%-51.83%23.83%24.89%31.39%
Free Cash Flow Margin
-16.69%-8.45%17.77%7.48%9.03%
EBITDA
16.6-175.19237.89206.04183.49
EBITDA Margin
3.19%-33.31%32.61%34.67%42.62%
D&A For EBITDA
4.577.23.542.421.94
EBIT
12.03-182.39234.35203.62181.55
EBIT Margin
2.31%-34.67%32.12%34.26%42.17%
Effective Tax Rate
--23.52%24.68%23.94%
Advertising Expenses
----7.54
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.